Literature DB >> 2938848

Measurement of transstenotic pressure gradient during percutaneous transluminal coronary angioplasty.

H V Anderson, G S Roubin, P P Leimgruber, W R Cox, J S Douglas, S B King, A R Gruentzig.   

Abstract

Obstruction to blood flow is accompanied by a pressure gradient across the obstructed site. In certain clinical settings, magnitude of pressure gradient has been used to judge severity of obstruction, and gradient reduction to judge success of an interventional procedure. In percutaneous transluminal coronary angioplasty (PTCA) the relationships between transstenotic pressure gradient, diameter stenosis, and lesion length are imprecisely known. We therefore examined 4263 sets of measurements in patients who underwent PTCA on single, discrete coronary arterial lesions. Multivariate regression analysis demonstrated that pressure gradient was artifactually elevated by about 12 mm Hg at low values of diameter stenosis but increased by the 4th power of stenosis as expected from fluid dynamics models. Pressure gradient was dampened and relatively constant at values of diameter stenosis of 60% or higher, probably because of total or near-total occlusion of the artery. Lesion length was not found to influence pressure gradient. Reductions in diameter stenosis (delta D) and pressure gradient (delta G) were related nonlinearly, with delta D proportional to the square root of delta G, suggesting that a reduction in gradient is directly proportional to an increase in cross-sectional area of the stenosis. The predictive value of final post-PTCA pressure gradients was found: a final gradient of 15 mm Hg or less predicted a final post-PTCA diameter stenosis of 30% or less, with 75% sensitivity and 29% specificity (p less than .01). The results of this study suggest that (1) pressure gradient as currently measured during PTCA is related to diameter stenosis but not to lesion length (2) reductions in pressure gradient and diameter stenosis are nonlinearly related.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 2938848     DOI: 10.1161/01.cir.73.6.1223

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Approaches for non-invasive assessment of endothelial function: focus on peripheral arterial tonometry.

Authors:  J J Kandhai-Ragunath; H T Jørstad; F H A F de Man; R J G Peters; C von Birgelen
Journal:  Neth Heart J       Date:  2013-05       Impact factor: 2.380

2.  Postprocedural resistance of the target lesion is a strong predictor of subsequent revascularization: assessment by a novel lesion-specific physiological parameter, the epicardial resistance index.

Authors:  Kazuhito Suzuki; Yukio Tsurumi; Yuji Fuda; Yasuhiro Ishii; Atsushi Takagi; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

3.  Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio.

Authors:  Nils P Johnson; Wenguang Li; Xi Chen; Barry Hennigan; Stuart Watkins; Colin Berry; William F Fearon; Keith G Oldroyd
Journal:  Eur Heart J       Date:  2019-08-14       Impact factor: 29.983

Review 4.  Assessment of coronary physiology - the evidence and implications.

Authors:  Noman Ali; Peysh A Patel; Christopher J Malkin
Journal:  Clin Med (Lond)       Date:  2019-09       Impact factor: 2.659

5.  Assessing the success of percutaneous transluminal coronary angioplasty.

Authors:  P D Bourdillon
Journal:  Br Heart J       Date:  1987-09

Review 6.  Physiological aspects of percutaneous transluminal coronary angioplasty.

Authors:  H Kline
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

Review 7.  Physiology-Guided Management of Serial/Diffuse Coronary Artery Disease.

Authors:  Christopher S G Murray; Tariq Siddiqui; Norma Keller; Solaiman Chowdhury; Tamanna Nahar
Journal:  Curr Cardiol Rep       Date:  2019-03-07       Impact factor: 2.931

Review 8.  Physiological Assessment of Coronary Lesions in 2020.

Authors:  Mohsin Chowdhury; Eric A Osborn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-01-15

9.  Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty.

Authors:  Ae-Young Her; Eun-Seok Shin; Joo Myung Lee; Scot Garg; Joon-Hyung Doh; Chang-Wook Nam; Bon-Kwon Koo
Journal:  Int J Cardiovasc Imaging       Date:  2018-04-26       Impact factor: 2.357

Review 10.  Coronary circulation: Pressure/flow parameters for assessment of ischemic heart disease.

Authors:  Henry Gewirtz
Journal:  J Nucl Cardiol       Date:  2018-04-10       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.